Elevated serum granulocyte-macrophage colony-stimulating factor levels during radiotherapy predict favorable outcomes in lung and esophageal cancer

The combination of exogenous granulocyte-macrophage colony-stimulating factor (GM-CSF) with radiotherapy (RT) has been demonstrated to strengthen the antitumor immune response. We hypothesized that the variation of GM-CSF during RT was correlated with cancer prognosis. We measured serum levels of GM...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Guodong, Hu, Pingping, Zhang, Jingxin, Liu, Qiqi, Liang, Ning, Xie, Jian, Qiao, Lili, Luo, Hui, Xu, Deguo, Liu, Fengjun, Yu, Xinshuang, liu, Zhen, Lv, Yajuan, Zhang, Jiandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356724/
https://www.ncbi.nlm.nih.gov/pubmed/27835886
http://dx.doi.org/10.18632/oncotarget.13202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356724/
https://www.ncbi.nlm.nih.gov/pubmed/27835886
http://dx.doi.org/10.18632/oncotarget.13202

Ejemplares similares